Over the last decade or so, running shoe technology has been progressing at an alarming rate, with more and more manufacturers pouring money into their R&D programs so that they can come out with a product that’ll put the competition to shame. In fact, these days, it’s something of an innovation arms race, a cutthroat environment in which the strong survive and the weak are sent packing.
While Brooks has always served as one of the industry’s mainstays, it’s never been a brand known for going big and taking chances. Or rather, that used to be the case. However, the shoe pictured before you — dubbed the Aurora-BL — is unlike anything we’ve ever seen. For starters, it features an all-new nitrogen-injected foam known as DNA LOFT V3, an addition that promises to be incredibly soft, lightweight, and plenty responsive underfoot. What’s more, it’s based around a decoupled midsole design that allows for the forefoot and the heel to move independently, effectively smoothening a runner’s stride whilst also reducing injury risk at the knee. It’ll be available for $200 starting June 17th, but you can learn more in the meantime at the link below.